Salesforce, Inc. is a top pick, poised for strong top line growth and robust margin expansion despite AI disruption fears.

Objective This study aimed to evaluate the prevalence and predictors of cardiovascular disease (CVD), chronic kidney disease ...

Objective This study aims to assess the prevalence of cancer risk factors in China’s working population and provide evidence for formulating more targeted workplace cancer prevention strategies.

Introduction Compared with other high-income countries, the USA continues to have the highest rates of pregnancy-related and associated mortality and morbidity (PRAMM), particularly in rural areas and ...

This important study provides a detailed analysis of the transcriptional landscape of the mouse hippocampus in the context of various physiological states. The main conclusions have solid support: ...

Discover how efficiency variance reveals the gap between expected and actual inputs in production and its impact on labor, materials, and costs.

Background Heart auscultation is a widely used and cost-effective clinical tool for detecting valvular heart disease (VHD), particularly in primary care. However, existing evidence on its diagnostic ...

The use of network meta-analysis (NMA) in sport and exercise medicine (SEM) research continues to rise as it enables the comparison of multiple interventions that may not have been assessed in a ...

If you are searching for ways to transform your Excel monthly tasks into a more streamlined, effortless process, you might be interested in a new tutorial created by the team at Excel Off The Grid. If ...

If you are struggling to keep track of performance metrics and identify areas needing improvement? You will be pleased to know that you are not alone. Many people find it challenging to sift through ...

We’ll pick up from the previous section on hierarchical modeling with Bayesian meta-analysis, which lends itself naturally to a hierarchical formulation, with each study an “exchangeable” unit. Let’s ...

Background Per cent slowing of decline is frequently used as a metric of outcome in Alzheimer’s disease (AD) clinical trials, but it may be misleading. Our objective was to determine whether per cent ...